​Nakanoshima Qross Health Accelerator: Special Open Session

​Gateway to the UK: Scaling Health Innovation from Japan

​How can Japanese health and MedTech startups successfully enter and scale in the UK?

​The Nakanoshima Qross Health Accelerator (NQHA) is a globally focused startup support program delivered under the NQ Global Startup Gateway, an initiative led by the @Osaka Prefectural Government to build globally competitive startups and position Nakanoshima as an international innovation hub.

​Through tailored acceleration and overseas immersion programs, NQHA supports founders to commercialise globally. The program is jointly delivered by AstraZeneca, Cambridge Consultants, and MedTech Actuator, with a strong focus on international market entry.

​Join us in Osaka for a special open session of NQHA. This panel discussion will explore strategic positioning for healthcare and MedTech startups targeting the UK market—featuring leaders with first-hand experience across regulation, the NHS, investment, and commercial pathways.

​Speakers include

• ​Dr. Yu Moriguchi — Assistant to the Chairman, Future Medical Innovation Promotion Organization

• ​Michael Blyth — British Consul-General in Osaka

• ​Claire Richardson — CEO, GHS Clinics

• ​Maki Kawaminami — Senior Investment Officer, British Consulate-General Osaka

• ​Lei Liu — Director, Innovation Partnerships, Commercial Excellence Division, AstraZeneca K.K.

• ​Buzz Palmer — CEO, MedTech Actuator

​ Event details

• ​Wednesday 28 January

• ​Nakanoshima Qross, Osaka, Japan

• ​4:00 – 6:00 pm

​If you’re a founder, innovator, or ecosystem partner exploring the UK as your next growth market, this is a conversation not to miss.

*Please note that this event will be conducted in English.

*Please note that photographs and videos will be taken during the event for promotional purposes (SNS, website, etc.). By attending, you agree to being filmed or photographed.